ConductScience.org, home

Gene · 9476

NAPSA: napsin A aspartic peptidase

12 sourcesgene-search-2026-11-11-0.2.0

Download JSON
Cite this record

ConductScience Library. NAPSA: napsin A aspartic peptidase. Genes, record 9476. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/9476

On this page

Gene

Symbol
NAPSA
HGNC
Name
napsin A aspartic peptidase
HGNC
NCBI Gene ID
9476
NCBI Gene
HGNC ID
HGNC:13395
HGNC
Ensembl
ENSG00000131400
NCBI Gene
Aliases
KAP, Kdap, NAP1, NAPA, NR1H2-AS1, SNAPA
NCBI Gene
Type
protein-coding
NCBI Gene

Proteins1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated in
O96009Napsin-A4200Ensembl, GeneID, HGNC

Source UniProt

Patents60

Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.

PublicationPublishedSEQ ID NOProteinSource
EP 4650780 A22025-11-191465O96009Espacenet
EP 4641201 A22025-10-291080O96009Espacenet
JP 2025147176 A2025-10-069174O96009Espacenet
JP 2025138725 A2025-09-251897O96009Espacenet
JP 2025529142 A2025-09-047115O96009Espacenet
US 12371689 B22025-07-297115O96009Espacenet
JP 2025517969 A2025-06-121080O96009Espacenet
JP 2025517970 A2025-06-121465O96009Espacenet
JP 2025028160 A2025-02-289174O96009Espacenet
KR 1020250010750 A2025-01-219174O96009Espacenet

1 to 10 of 60

See all 60 patents

Drugs0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

None in this release.

Trials0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

None in this release.

NIH grants618

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleNAPSA papersNewest fiscal year
P30CA008748Cancer Center Support Grant392025
R01HL095993Derivation of lung epithelia from iPS cells for advanced disease modeling102025
P30CA016672Cancer Center Support Grant82025
P30ES013508Center of Excellence in Environmental Toxicology42025
P40OD010440Caenorhabditis Genetics Center42025
UL1TR001863Yale Clinical and Translational Science Award42025
P30CA016058Cancer Center Support Grant32025
P30CA033572Cancer Center Support Grant32025
P30CA071789University of Hawaii Cancer Center CCSG32025
P30CA076292Moffitt Cancer Center Support Grant32025

1 to 10 of 618Source NIH's project files

See all 618 nih grants

Papers2,888

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
Small-Bowel Perforation Caused by Multiple Metastases from Lung Adenocarcinoma Preceded by Obscure Gastrointestinal Bleeding: A Case Report.Surg Case Rep202642787081PubTator, text miningPubMed
Case Report: Invasive mucinous adenocarcinoma mimicking interstitial pneumonia with autoimmune features: diagnostic pitfalls and reflections.Front Immunol202642774218PubTator, text miningPubMed
[A Case of Stage Ⅳ Lung Adenocarcinoma with Bilateral Breast Metastases Mimicking Inflammatory Breast Cancer].Gan To Kagaku Ryoho202642750623PubTator, text miningPubMed
Combining Napsin A expression with circulating tumor cell counts for enhanced identification of pulmonary adenocarcinoma in ground-glass nodules.Transl Cancer Res202642724459PubTator, text miningPubMed
Case Report: Synchronous SCLC and minimally invasive adenocarcinoma in the same lobe: NGS-confirmed cross-histological molecular heterogeneity in an ultra-rare case.Front Oncol202642723765PubTator, text miningPubMed
Staged traditional Chinese medicine treatment for suspected pulmonary inflammatory pseudotumor with progressive lesion reduction: a case report and literature review.Front Med (Lausanne)202642694241PubTator, text miningPubMed
Case Report: Hidden danger in breast eczematous lesions: cutaneous metastasis from silent lung adenocarcinoma misdiagnosed as Paget's disease.Front Oncol202642688082PubTator, text miningPubMed
Case Report: Synchronous ALK-positive laryngeal inflammatory myofibroblastic tumor and EGFR-mutant lung adenocarcinoma in a child.Front Pediatr202642625736PubTator, text miningPubMed
An Unusual Low-Grade Biphasic Pulmonary Neoplasm Harboring BRAF-V600E Mutation: A Potential Variant of Bronchiolar Adenoma.Int J Surg Pathol202642595357PubTator, text miningPubMed
ALK-rearranged lung adenocarcinoma transforming to mucoepidermoid carcinoma in a 45-year-old female: a case report.AME Case Rep202642592384PubTator, text miningPubMed

1 to 10 of 2,888

See all 2,888 papers

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this gene from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/genes/v1/9476

GET https://conductscience.org/api/genes/v1/9476/patents?page=2